Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving PRO Interpretation at the Individual Level for Patients With Cancer Using Conversational Agents and Data Visualization - Aim 3

NCT05948618 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT05948618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05948618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving PRO Interpretation at the Individual Level for Patients With Cancer Using Conversational Agents and Data Visualization - Aim 3
Lead sponsor
Tufts Medical Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 24, 2025
Completion date
September 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer